收藏切换
Interpretation of the scientific statement from American Heart Association: cancer therapy-related hypertension
收藏切换
Changyuan LIU1, 2, Xin CHEN1, 2, *
World Clinical Drug | 2023, 44(8) : 767 - 772
Less
收藏切换
World Clinical Drug | 2023, 44(8): 767-772
• Topic •
Interpretation of the scientific statement from American Heart Association: cancer therapy-related hypertension
Full
Changyuan LIU1, 2, Xin CHEN1, 2, *
Affiliations
  • 1.Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 201801, China
  • 2.Shanghai Institute of Hypertension, Shanghai 200001, China
Published: 2023-08-10 doi: 10.13683/j.wph.2023.08.001
Outline
收藏切换

Now there is growing evidence supporting the association between hypertension and tumors, and the two diseases have some common epidemiological and pathophysiological characteristics. Although antineoplastic drugs greatly improve survival rate of cancer patients, they increase the risk of cardiovascular disease including cardiac disease, thrombotic disease and hypertension. Studies have confirmed that a variety of antineoplastic drugs can cause or worsen hypertension, which in turn is an associated risk factor for certain cancers (e.g., renal cell carcinoma, colorectal cancer). In addition, drug interactions and some other adjuvant drugs in tumor therapy also have the potential to elevate the risk of hypertension. In January 2023, the American Heart Association published a scientific statement on cancer therapy-related hypertension, which aims to elucidate the epidemiology of antineoplastic drugs, the possible mechanisms that cause hypertension, and the diagnosis and management of hypertension due to cancer therapy drugs, and to identify important issues that need to be addressed and to provide recommendations and guidance. This article interpreted this scientific statement and provides a reference for the clinical diagnosis and treatment of cancer therapy-related hypertension in China.

treatment of tumor  /  hypertension  /  interpretation of guide
刘常远, 陈歆. 美国心脏协会肿瘤治疗相关高血压科学声明解读. 世界临床药物, 2023 , 44 (8) : 767 -772 . DOI: 10.13683/j.wph.2023.08.001
Changyuan LIU, Xin CHEN. Interpretation of the scientific statement from American Heart Association: cancer therapy-related hypertension[J]. World Clinical Drug, 2023 , 44 (8) : 767 -772 . DOI: 10.13683/j.wph.2023.08.001
Year 2023 volume 44 Issue 8
10
1
Cite this Article
BibTeX
Article Info
doi: 10.13683/j.wph.2023.08.001
  • Receive Date:2023-03-27
  • Online Date:2026-11-18
  • Published:2023-08-10
Article Data
Affiliations
History
  • Received:2023-03-27
Funding
Affiliations
    1.Department of Hypertension, Ruijin Hospital, Shanghai Jiaotong University School of Medicine, Shanghai 201801, China
    2.Shanghai Institute of Hypertension, Shanghai 200001, China
References
Share
https://castjournals.cast.org.cn/joweb/sjlcyw/EN/10.13683/j.wph.2023.08.001
Share to
QR

Scan QR to access full text

Cite this article
BibTeX
Citations
表12种不同金属材料的力学参数
科
Family
属数
Number of
genus
种数
Number of
species
占总种数比例
Percentage of
total species (%)
属
Genus
种数
Number of
species
占总种数比例
Percentage of total
species (%)
鹅膏菌科Amanitaceae 2 11 5.26 鹅膏菌属 Amanita 10 4.78
小菇科 Mycenaceae 2 12 5.74 丝盖伞属 Inocybe 5 2.39
多孔菌科 Polyporaceae 8 14 6.70 蜡蘑属 Laccaria 5 2.39
红菇科 Russulaceae 3 23 11.00 小皮伞属 Marasmius 6 2.87
小菇属 Mycena 11 5.26
光柄菇属 Pluteus 5 2.39
红菇属 Russula 17 8.13
栓菌属 Trametes 5 2.39
关闭全屏
  • BibTeX
  • EndNote
  • RefWorks
  • TxT